Comparison

PQCA

Item no. CS-0065722-25mg
Manufacturer ChemScene
Amount 25mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1144504-35-7
Similar products 1144504-35-7
Available
CAS
1144504-35-7
Purity
>98%
MWt
388.42
Formula
C22H20N4O3
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 80C)
Clinical Information
No Development Reported
Pathway
Neuronal Signaling; GPCR/G Protein
Target
mAChR; mAChR
Biological Activity
PQCA is a highly selective and potent muscarinic M1 receptor positive allosteric modulator. PQCA has an EC50 value of 49 nM and 135 nM on rhesus and human M1 receptor, respectively. PQCA is inactive for other muscarinic receptors. PQCA has potential to reduce the cognitive deficits associated with Alzheimer's disease.
IC50 & Target: EC50: 49 nM (Rhesus M1 receptor) and 135 nM (Human M1 receptor)
In Vivo: PQCA (3-30 mg/kg; oral administration; single- or pair-housed male rhesus monkeys) treatment attenuates the scopolamine deficits in PAL and CPT tasks. Blockade of muscarinic signaling by scopolamine produces significant impairments in both tasks.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close